Bin Wu
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Renal cell carcinoma treatment 8
- Prostate Cancer Diagnosis and Treatment 7
- Surgery 20
- Co-authors
- Qiang Zhang (5 shared papers)Hu Zhao (11 shared papers)Zhenlei Zha (13 shared papers)Lizheng Shi (1 shared paper)Huafeng Chen (4 shared papers)Jun Yuan (11 shared papers)Jie Sun (1 shared paper)Ming Ye (5 shared papers)
- Journals
- Frontiers in Pharmacology (9 papers)PLoS ONE (6 papers)Frontiers in Oncology (4 papers)Medicine (3 papers)Value in Health (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Bin Wu
167 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 124
- Hepatology 189
- Pulmonary and Respiratory Medicine 660
- Oncology 505
- Internal Medicine 42
- Cancer Research 141
Countries citing papers authored by Bin Wu
This map shows the geographic impact of Bin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Wu more than expected).
Fields of papers citing papers by Bin Wu
This network shows the impact of papers produced by Bin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Wu. The network helps show where Bin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2009 | 131 | |
| 3 | 2018 | 104 | |
| 4 | 2012 | 88 | |
| 5 | 2013 | 76 | |
| 6 | 2022 | 68 | |
| 7 | 2019 | 65 | |
| 8 | 2018 | 65 | |
| 9 | 2018 | 60 | |
| 10 | 2017 | 59 | |
| 11 | 2018 | 54 | |
| 12 | 2018 | 53 | |
| 13 | 2010 | 52 | |
| 14 | 2018 | 52 | |
| 15 | 2011 | 51 | |
| 16 | 2018 | 48 | |
| 17 | 2016 | 47 | |
| 18 | 2020 | 46 | |
| 19 | 2021 | 44 | |
| 20 | 2023 | 43 |
About Bin Wu
Bin Wu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Epidemiology and Hepatology, having authored 176 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Hepatitis B Virus Studies (9 papers), Renal cell carcinoma treatment (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Hepatitis C virus research (7 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Hepatology (189 citations), Pulmonary and Respiratory Medicine (660 citations), Oncology (505 citations), Internal Medicine (42 citations) and Cancer Research (141 citations). Bin Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qiang Zhang, Hu Zhao, Zhenlei Zha, Lizheng Shi, Huafeng Chen, Jun Yuan, Jie Sun, Ming Ye, Lijin Zhang and Shun Lü. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Frontiers in Oncology, Medicine and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.